Search Ontology:
ChEBI
montbretin A
- Term ID
- CHEBI:144419
- Synonyms
-
- 2-(4-{[4-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-xylopyranosyl]oxy}-3,5-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranosyl-(1->2)-6-deoxy-alpha-
- myricetin 3-O-[beta-D-glucosyl-(1->2)-(6-O-caffeoyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside] 4'-O-[alpha-L-rhamnosyl-(1->4)-beta-D-xyloside]
- Definition
- A glycosyloxyflavone that is myricetin in which the hydroxy groups at the 3 and 4' positions have been glycosylated by an alpha-L-rhamnopyranosyl-(1->2)-6-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranosyl-(1->2)-alpha-L-rhamnopyranosyl group and a 4-O-(alpha-L-rhamnopyranosyl)-beta-D-xylopyranose group, respectively.
- References
-
- CAS:115712-92-0
- KNApSAcK:C00006047
- LIPID_MAPS_instance:LMPK12112449
- PMID:26214255
- PMID:31004005
- Patent:WO2009049428
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
- inverse is_conjugate_base_of
-
- is_conjugate_acid_of
-
Show first 5 Terms
Phenotype
Phenotype resulting from montbretin A
Phenotype where environments contain montbretin A
Phenotype modified by environments containing montbretin A
Human Disease Model